SMAD3 and renal fibrosis: A study (Liao et al. 2022) showed that EGCG improved renal fibrosis by inhibiting transforming growth factor‐beta 1 (TGF‐β)/mothers against decapentaplegic homolog 3 (Smad3) pathway in diabetic mice.